Chemokines in liver inflammation and fibrosis.

Chemokines may be involved in the tissue response to injury regulating the influx of leukocytes, and modulating a number of other critical biologic actions, including angiogenesis, neoplastic growth, myo-fibroblast activation, and the response to viral infections. In the liver, up-regulated expression of different members of the chemokine system may be induced by almost all types of injury, and there is often a clear relation between the chemokine pattern activated by different types of injury and the predominant subclasses of leukocytes which infiltrate the liver. Neutralization of specific chemokines by passive immunization or the use of animals deficient in specific chemokines or chemokine receptors has indicated a causal relation between up-regulation of chemokines and leukocyte infiltration. Inflammation is part of the liver wound healing response, that in chronic conditions leads to the development of fibrosis and cirrhosis. Hepatic stellate cells, which play a leading role in the development of fibrosis following their transition to myofibroblasts, express different chemokines. Chemokine expression by stellate cells is regulated by soluble mediators, in particular pro-inflammatory cytokines, as well as growth factors, proteases, and products of oxidative stress. In addition, stellate cells also respond to chemokines with biologic actions relevant for tissue repair, such as cell migration or induction of other chemokines. These data indicate that chemokines in the liver may modulate the progression of liver fibrosis through actions on hepatic stellate cells.

[1]  K. Matsushima,et al.  Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. , 1999, The Journal of clinical investigation.

[2]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[4]  H. Bonkovsky,et al.  Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. , 1998, Hepatology.

[5]  R. Bronson,et al.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. J. Valente,et al.  Identification of monocyte chemotactic activity produced by malignant cells. , 1989, Science.

[7]  N. Kaplowitz,et al.  Oxidative stress and liver disease. , 1996, Progress in liver diseases.

[8]  R. Strieter,et al.  Novel protective effects of stem cell factor in a murine model of acute septic peritonitis. Dependence on MCP-1. , 2000, The American journal of pathology.

[9]  A. Lentsch,et al.  Mechanisms of hypothermic protection against ischemic liver injury in mice. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[10]  G. Reynolds,et al.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. , 2002, The American journal of pathology.

[11]  K. Khabar,et al.  Elevated Levels of Interleukin-8 in Serum Are Associated with Hepatitis C Virus Infection and Resistance to Interferon Therapy , 2001, Journal of Virology.

[12]  N. Sheron,et al.  Circulating and tissue levels of the neutrophil chemotaxin interleukin‐8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration , 1993, Hepatology.

[13]  C. McClain,et al.  Increased plasma interleukin‐8 concentrations in alcoholic hepatitis , 1993, Hepatology.

[14]  C. Chan,et al.  Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival. , 1996, Journal of hepatology.

[15]  Edwards,et al.  Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and KC , 1998, Hepatology.

[16]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[17]  J. Teruya-Feldstein,et al.  Contribution of the CXC chemokines IP‐10 and Mig to the antitumor effects of IL‐12 , 1998, Journal of leukocyte biology.

[18]  S. Shaw,et al.  Stimulation of monocyte interleukin-8 by lipid peroxidation products: a mechanism for alcohol-induced liver injury. , 1998, Alcohol.

[19]  M. Burdick,et al.  Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. , 1995, The Journal of clinical investigation.

[20]  Shou-Dong Lee,et al.  Plasma interleukin‐8 levels in patients with post‐hepatitic cirrhosis: Relationship to severity of liver disease, portal hypertension and hyperdynamic circulation , 1996, Journal of gastroenterology and hepatology.

[21]  C. Degott,et al.  Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. , 2001, Journal of hepatology.

[22]  J. Maher,et al.  Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[23]  M. Burdick,et al.  PROLIFERATIVE EFFECTS OF CXC CHEMOKINES IN RAT HEPATOCYTES IN VITRO AND IN VIVO , 1998, Shock.

[24]  R. Strieter,et al.  Novel CXCR2‐dependent liver regenerative qualities of ELR‐containing CXC chemokines , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  A. Foussat,et al.  Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Standiford,et al.  MCP-1 protects mice in lethal endotoxemia. , 1997, The Journal of clinical investigation.

[27]  C. McClain,et al.  Increased monocyte MCP-1 production in acute alcoholic hepatitis. , 1999, Cytokine.

[28]  K. Matsushima,et al.  International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.

[29]  Y. Yamaguchi,et al.  Neutrophil elastase and oxygen radicals enhance monocyte chemoattractant protein- expression after ischemia/reperfusion in rat liver. , 1999, Transplantation.

[30]  D. Adams,et al.  Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1α in alcoholic liver disease , 1999, Gut.

[31]  A. Zlotnik,et al.  The biology of chemokines and their receptors. , 2000, Annual review of immunology.

[32]  K. S. Lee,et al.  Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. , 1995, The Journal of clinical investigation.

[33]  G. Bishop,et al.  Increased intrahepatic messenger RNA expression of interleukins 2, 6, and 8 in human cirrhosis. , 1994, Gastroenterology.

[34]  A. J. Valente,et al.  Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. , 1993, The Journal of clinical investigation.

[35]  R. Strieter,et al.  Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis. , 2000, Experimental and molecular pathology.

[36]  A. Lentsch,et al.  Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. , 1999, The Journal of surgical research.

[37]  L. Colletti,et al.  Lung and liver injury following hepatic ischemia/reperfusion in the rat is increased by exogenous lipopolysaccharide which also increases hepatic TNF production in vivo and in vitro. , 2001, Shock.

[38]  F. Marra,et al.  Monocyte chemotactic protein‐1 as a chemoattractant for human hepatic stellate cells , 1999, Hepatology.

[39]  S. Milani,et al.  Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. , 1999, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[40]  Y. Yamaguchi,et al.  Enhanced expression of cytokine‐induced neutrophil chemoattractant in rat hepatic allografts during acute rejection , 1997, Hepatology.

[41]  D. Adams,et al.  Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis , 1998, The Journal of pathology.

[42]  M. Miyazaki,et al.  IL-13 activates STAT6 and inhibits liver injury induced by ischemia/reperfusion. , 1999, The American journal of pathology.

[43]  A. Watanabe,et al.  CC‐chemokine receptor 6 and its ligand macrophage inflammatory protein 3α might be involved in the amplification of local necroinflammatory response in the liver , 2001, Hepatology.

[44]  K. Kohno,et al.  Alcoholic fatty liver differentially induces a neutrophil‐chemokine and hepatic necrosis after ischemia‐reperfusion in rat , 2000, Hepatology.

[45]  R. Caporale,et al.  Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. , 2000, Gastroenterology.

[46]  J. Ross,et al.  Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. , 1997, American journal of physiology. Endocrinology and metabolism.

[47]  P. Murphy Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.

[48]  S. Narula,et al.  Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. , 1999, Journal of immunology.

[49]  R. Strieter,et al.  IFN-γ-Inducible Protein-10 (CXCL10) Is Hepatoprotective During Acute Liver Injury Through the Induction of CXCR2 on Hepatocytes1 , 2001, The Journal of Immunology.

[50]  Hiroshi Matsumoto,et al.  Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat , 1999, Hepatology.

[51]  M. Burdick,et al.  The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. , 1996, Hepatology.

[52]  S. Milani,et al.  Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. , 1998, The American journal of pathology.

[53]  A. Lentsch,et al.  Interleukin‐10 suppresses hepatic ischemia/reperfusion injury in mice: Implications of a central role for nuclear factor κB , 1999, Hepatology.

[54]  G. Barber,et al.  Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin-8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response , 2001, Journal of Virology.

[55]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[56]  K. Matsushima,et al.  Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. , 1998, The Journal of clinical investigation.

[57]  G. Karupiah,et al.  Transcription of the interferon gamma (IFN-gamma )-inducible chemokine Mig in IFN-gamma-deficient mice. , 2001, The Journal of biological chemistry.

[58]  M. Czaja,et al.  Monocyte chemoattractant protein 1 (MCP‐1) expression occurs in toxic rat liver injury and human liver disease , 1994, Journal of leukocyte biology.

[59]  F. Marra Hepatic stellate cells and the regulation of liver inflammation. , 1999, Journal of hepatology.

[60]  R. Strieter,et al.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.

[61]  K. Kharbanda,et al.  Brief communication Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells , 2001 .

[62]  D. Adams,et al.  Hepatic expression of macrophage inflammatory protein-1 alpha and macrophage inflammatory protein-1 beta after liver transplantation. , 1996, Transplantation.

[63]  C. Mackay,et al.  Monocyte chemotactic protein‐1, ‐2, and ‐3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis , 2001, The Journal of pathology.

[64]  Ping Zhang,et al.  ATTENUATION OF HEPATIC NEUTROPHIL SEQUESTRATION BY ANTI‐CINC ANTIBODY IN ENDOTOXIC RATS , 1995, Shock.

[65]  J. Maher Rat hepatocytes and Kupffer cells interact to produce interleukin-8 (CINC) in the setting of ethanol. , 1995, The American journal of physiology.

[66]  J. Wigginton,et al.  Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). , 2001, Journal of immunology.

[67]  Y. Tominaga,et al.  Expression of IFN-inducible protein-10 in chronic hepatitis. , 1997, Journal of immunology.

[68]  N. Horiike,et al.  Increased serum levels of macrophage inflammatory protein‐3α in chronic viral hepatitis: prognostic importance of macrophage inflammatory protein‐3α during interferon therapy in chronic hepatitis C , 2002, Journal of viral hepatitis.

[69]  J. Maher,et al.  Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. , 1998, The American journal of physiology.

[70]  S. Milani,et al.  Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. , 2002, Journal of hepatology.

[71]  M. Mori,et al.  Reduced expression of the CXC chemokine hIRH/SDF‐1α mRNA in hepatoma and digestive tract cancer , 1997, International journal of cancer.

[72]  B. Rollins,et al.  Chemokines and disease , 2001, Nature Immunology.

[73]  M. Czaja,et al.  Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. , 1996, Gastroenterology.

[74]  R. Schwabe,et al.  CD40 Activates NF-κB and c-Jun N-Terminal Kinase and Enhances Chemokine Secretion on Activated Human Hepatic Stellate Cells1 , 2001, The Journal of Immunology.

[75]  A. J. Valente,et al.  Agonist‐specific regulation of monocyte chemoattractant protein‐1 expression by cyclooxygenase metabolites in hepatic stellate cells , 2001, Hepatology.

[76]  D. Brenner,et al.  Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. , 1998, The American journal of physiology.

[77]  J. Cyster,et al.  Chemokines as regulators of T cell differentiation , 2001, Nature Immunology.

[78]  S. Kunkel,et al.  Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. , 2000, The American journal of pathology.

[79]  G. Su,et al.  Increased severity of alcoholic liver injury in female rats: role of oxidative stress, endotoxin, and chemokines. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[80]  J. Kolls,et al.  Acute alcohol intoxication suppresses the CXC chemokine response during endotoxemia. , 2002, Alcoholism, clinical and experimental research.

[81]  G. McCaughan,et al.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection , 2000, Gut.

[82]  M. Serio,et al.  Signal Transduction by the Chemokine Receptor CXCR3 , 2001, The Journal of Biological Chemistry.

[83]  J. Kuratsu,et al.  Monocyte chemoattractant protein‐1 enhances expression of intercellular adhesion molecule‐1 following ischemia‐reperfusion of the liver in rats , 1998, Hepatology.

[84]  A. Lentsch,et al.  Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). , 2000, Blood.

[85]  G. Gerken,et al.  Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity , 1995, Hepatology.

[86]  V. Carloni,et al.  Integrin‐mediated stimulation of monocyte chemotactic protein‐1 expression , 1997, FEBS letters.

[87]  K. Matsushima,et al.  Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease , 2001, The Journal of experimental medicine.

[88]  N. Habib,et al.  Hepatic ischemia-reperfusion injury. , 2001, American journal of surgery.

[89]  M. Abe,et al.  Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis. , 1998, Hepato-gastroenterology.

[90]  D. Adams,et al.  Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. , 1999, Journal of immunology.

[91]  G. Karupiah,et al.  The Interferon-Inducible Chemokines MuMig and Crg-2 Exhibit Antiviral Activity In Vivo , 1999, Journal of Virology.

[92]  D. Adams,et al.  Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro. , 1997, Proceedings of the Association of American Physicians.

[93]  G. Ramadori,et al.  Enhanced Expression of Interferon-Regulated Genes in the Liver of Patients with Chronic Hepatitis C Virus Infection: Detection by Suppression-Subtractive Hybridization , 2001, Journal of Virology.

[94]  J. Iredale,et al.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.

[95]  A. Farhood,et al.  Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[96]  D. Adams,et al.  Expression and function of CXC and CC chemokines in human malignant liver tumors: A role for human monokine induced by γ‐interferon in lymphocyte recruitment to hepatocellular carcinoma , 1999, Hepatology.

[97]  Y. Shiratori,et al.  Production of chemotactic factor, interleukin‐8, from hepatocytes exposed to ethanol , 1993, Hepatology.

[98]  L. Toledo-Pereyra,et al.  L-Selectin and chemokine response after liver ischemia and reperfusion. , 2000, The Journal of surgical research.

[99]  J. Cyster,et al.  Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.

[100]  W. Alvord,et al.  T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. , 1998, Journal of immunology.

[101]  K. Mimori,et al.  Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2. , 2001, Cellular signalling.

[102]  S. Friedman Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[103]  J. Maher,et al.  Adenovirus‐mediated expression of cytokine‐induced neutrophil chemoattractant in rat liver induces a neutrophilic hepatitis , 1997, Hepatology.

[104]  L. Koniaris,et al.  Cytokine-Responsive Gene-2/IFN-Inducible Protein-10 Expression in Multiple Models of Liver and Bile Duct Injury Suggests a Role in Tissue Regeneration1 , 2001, The Journal of Immunology.

[105]  K. Matsushima,et al.  Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. , 2000, Cytokine.

[106]  F. Marumo,et al.  Expression of C-C Chemokines is Associated with Portal and Periportal Inflammation in the Liver of Patients with Chronic Hepatitis C , 2000, Laboratory Investigation.

[107]  M. Burdick,et al.  The ratio of ELR+ to ELR− CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat , 2000, Hepatology.

[108]  M. Dziejman,et al.  IFN-γ-Inducible Protein 10 (IP-10; CXCL10)-Deficient Mice Reveal a Role for IP-10 in Effector T Cell Generation and Trafficking1 , 2002, The Journal of Immunology.

[109]  F. Chisari,et al.  Blocking Chemokine Responsive to γ–2/Interferon (IFN)-γ Inducible Protein and Monokine Induced by IFN-γ Activity In Vivo Reduces the Pathogenetic but not the Antiviral Potential of Hepatitis B Virus–specific Cytotoxic T Lymphocytes , 2001, The Journal of experimental medicine.

[110]  S. Murakami,et al.  Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. , 1991, The Journal of biological chemistry.

[111]  A. Gressner,et al.  Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. , 1997, Gastroenterology.

[112]  N. Sheron,et al.  Chemokine levels in human liver homogenates: Associations between GRO α and histopathological evidence of alcoholic hepatitis , 1996, Hepatology.

[113]  A. Bansal,et al.  Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis. , 1997, Autoimmunity.

[114]  L. Toledo-Pereyra,et al.  P-selectin and chemokine response after liver ischemia and reperfusion. , 2000, Journal of the American College of Surgeons.

[115]  S. Milani,et al.  Expression of the thrombin receptor in human liver: Up‐regulation during acute and chronic injury , 1998, Hepatology.

[116]  N. Copeland,et al.  The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[117]  D. Adams,et al.  Differential expression of chemokines and chemokine receptors shapes the inflammatory response in rejecting human liver transplants. , 2001, Transplantation.

[118]  A. Gressner,et al.  Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. , 1999, Journal of hepatology.

[119]  C. Biron,et al.  A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. , 2000, The Journal of clinical investigation.

[120]  C. Chitnis,et al.  A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.